Norway· NO-ID_C734FEE2-4FA3-4543-9B58-ABEC338C71B0
Epidyolex
A cannabidiol product containing cannabidiol, registered in Norway by Jazz Pharmaceuticals Ireland Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Cannabidiol is registered in 14 of 19 countries.
Countries holding a registration under ATC N03AX24 (cannabidiol), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Cannabidiol · ATC N03AX24
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Cannabidiol
- Manufacturer
- Jazz Pharmaceuticals Ireland Limited
- Country
- Norway (NO)
- ATC code
- N03AX24
- ATC class
- Cannabidiol
- Defined daily dose
- 0.7 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_C734FEE2-4FA3-4543-9B58-ABEC338C71B0
- no_varenummer400959100NOK 15544.9
- gtin5055813900073
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
277 interactions on record for cannabidiol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cannabidiol · interactions on record
277 records
- 4 severe
- 251 moderate
- 22 minor
Most severe, free to view
- ClotrimazoleA01AB18moderate
- MetoclopramideA03FA01moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cannabidiol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEPIDYOLEXJazz Pharmaceuticals Ireland Ltd, Dublin
- United StatesEpidiolexJazz Pharmaceuticals, Inc.
- FinlandEpidyolexJazz Pharmaceuticals Ireland Limited
- FranceEPIDYOLEX 100 mg/mL, solution buvableJAZZ PHARMACEUTICALS IRELAND LIMITED (IRLANDE)
- BelgiumEpidyolex 100 mg/mlJazz Pharmaceuticals Ireland
- IcelandEpidyolexJazz Pharmaceuticals Ireland Ltd
- NetherlandsEpidyolex 100 mg/ml, drankJazz Pharmaceuticals Ireland Limited
- PolandEpidyolexJazz Pharmaceuticals Ireland Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Epidyolex
- Liechtenstein · Epidyolex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef8d41d5-3100-4688-ac86-e5361401f1ea GET /v1/drugs/ef8d41d5-3100-4688-ac86-e5361401f1ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Mikstur, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Cannabidiol",
"merkevare_id": "ID_C734FEE2-4FA3-4543-9B58-ABEC338C71B0",
"name_form_strength": "Epidyolex mikst oppl 100 mg/ml",
"prescription_group": "A"
}See everything about cannabidiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.